New therapeutic targeting of Alzheimer’s disease with the potential use of proline-rich polypeptide complex to modulate an innate immune response - preliminary study

BACKGROUND: The lack of effective treatment for Alzheimer’s disease (AD) stems mainly from the incomplete understanding of AD causes. Neuroinflammation has emerged as an important component of AD pathology, and a vast number of experimental and clinical data indicated a crucial role for the activati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sochocka, Marta, Ochnik, Michał, Sobczyński, Maciej, Siemieniec, Iwona, Orzechowska, Beata, Naporowski, Piotr, Leszek, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612126/
https://www.ncbi.nlm.nih.gov/pubmed/31277647
http://dx.doi.org/10.1186/s12974-019-1520-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612126/
https://www.ncbi.nlm.nih.gov/pubmed/31277647
http://dx.doi.org/10.1186/s12974-019-1520-6

Ejemplares similares